2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| NSV Investments I, L.P. | — | 13,274,786 | Dec 15, 2022 |
| NSV Partners III LP | 10% Owner | 7,102,969 | Jun 26, 2024 |
| NSV Partners III GP LLC | 10% Owner | 7,102,969 | Jun 26, 2024 |
| Subramaniam Somu | Director | 4,032,213 | Apr 1, 2025 |
| Nuss John | CHIEF SCIENTIFIC OFFICER | 467,226 | Apr 3, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 4, 2026 | Gonzales Roy | Senior VP, Finance | Neutral | 47.5 | -5,313 | -100.00% | ✗ | - |
| Mar 4, 2026 | Mar 4, 2026 | Subramaniam Somu | Director | Neutral | 47.5 | -3,337,495 | -100.00% | ✗ | - |
| Mar 4, 2026 | Mar 4, 2026 | White William Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 4, 2026 | Mar 4, 2026 | Moore Matthew Richard | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 4, 2026 | Mar 4, 2026 | Cadoret-Manier Onaiza | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 4, 2026 | Mar 4, 2026 | HULME ALLISON | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 4, 2026 | Mar 4, 2026 | GUJRATHI SHEILA | Director | Neutral | 47.5 | -130,000 | -100.00% | ✗ | - |
| Mar 4, 2026 | Mar 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | Neutral | 47.5 | -489,481 | -100.00% | ✗ | - |
| Mar 4, 2026 | Mar 4, 2026 | Mohan Raju | CEO | Neutral | 47.5 | -2,372,863 | -100.00% | ✗ | - |
| Mar 4, 2026 | Mar 4, 2026 | Forman Mark S | Chief Medical Officer | Neutral | 47.5 | -6,000 | -100.00% | ✗ | - |
| Feb 27, 2026 | Mar 3, 2026 | Subramaniam Somu | Director | Neutral | 27.5 | -694,718 | -17.23% | ✗ | - |
| Dec 17, 2025 | Dec 19, 2025 | Mohan Raju | CEO | Sell | 40.0 | -47,345 | -1.96% | ✗ | $365.5K |
| Dec 17, 2025 | Dec 19, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 42.5 | -12,675 | -2.52% | ✗ | $97.8K |
| Nov 17, 2025 | Nov 19, 2025 | Forman Mark S | Chief Medical Officer | Neutral | 90.0 | +3,000 | 100.00% | ✗ | - |
| Nov 17, 2025 | Nov 19, 2025 | Gonzales Roy | Senior VP, Finance | Neutral | 90.0 | +1,767 | 49.83% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | Cadoret-Manier Onaiza | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | HULME ALLISON | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | Subramaniam Somu | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | White William Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | Gujrathi Sheila | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 15, 2025 | May 16, 2025 | Gonzales Roy | Senior VP, Finance | Neutral | 90.0 | +1,750 | 97.44% | ✗ | - |
| May 15, 2025 | May 16, 2025 | Forman Mark S | Chief Medical Officer | Neutral | 90.0 | +3,000 | 100.00% | ✗ | - |
| Apr 2, 2025 | Apr 3, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 52.5 | -1,887 | -0.40% | ✗ | $2K |
| Mar 28, 2025 | Apr 1, 2025 | Mohan Raju | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 28, 2025 | Apr 1, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 28, 2025 | Apr 1, 2025 | Subramaniam Somu | Director | Neutral | 27.5 | -1,335,450 | -24.88% | ✗ | - |
| Mar 10, 2025 | Mar 12, 2025 | Subramaniam Somu | Director | Neutral | 27.5 | -1,735,306 | -24.43% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Mohan Raju | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Moore Matthew Richard | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Gonzales Roy | Senior VP, Finance | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2025 | Jan 3, 2025 | Forman Mark S | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 27, 2024 | Dec 30, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 26.3 | -21,119 | -4.35% | ✗ | $49.8K |
| Dec 23, 2024 | Dec 26, 2024 | Gujrathi Sheila | Director | Buy | 97.5 | +130,000 | 100.00% | ✗ | $300.6K |
| Dec 17, 2024 | Dec 19, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 46.3 | -13,161 | -2.64% | ✗ | $29.7K |
| Dec 17, 2024 | Dec 19, 2024 | Mohan Raju | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 10, 2024 | Dec 11, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 22, 2024 | Nov 25, 2024 | Mohan Raju | CEO | Buy | 97.5 | +500,000 | 29.85% | ✗ | $959.9K |
| Sep 9, 2024 | Gonzales Roy | Senior VP, Finance | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 12, 2024 | Aug 13, 2024 | Forman Mark S | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 13, 2024 | Forman Mark S | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 24, 2024 | Jun 26, 2024 | NSV Partners III LP | 10% Owner | Neutral | 27.5 | -641,327 | -8.28% | ✗ | - |
| Jun 24, 2024 | Jun 26, 2024 | Subramaniam Somu | Director | Neutral | 27.5 | -641,327 | -8.28% | ✗ | - |
| Jun 10, 2024 | Jun 11, 2024 | Mohan Raju | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | White William Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | Cadoret-Manier Onaiza | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | Gujrathi Sheila | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | HULME ALLISON | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2024 | Jun 7, 2024 | Subramaniam Somu | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 16, 2024 | May 17, 2024 | Moore Matthew Richard | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 17, 2024 | Moore Matthew Richard | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 12, 2024 | Apr 16, 2024 | Subramaniam Somu | Director | Neutral | 27.5 | -695,339 | -8.24% | ✗ | - |
| Apr 12, 2024 | Apr 16, 2024 | NSV Partners III LP | 10% Owner | Neutral | 27.5 | -695,339 | -8.24% | ✗ | - |
| Apr 2, 2024 | Apr 3, 2024 | Krueger Christopher W | CHIEF BUSINESS OFFICER | Sell | 50.0 | -1,651 | -0.58% | ✗ | $8.9K |
| Apr 2, 2024 | Apr 3, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 50.0 | -1,651 | -0.62% | ✗ | $8.9K |
| Apr 2, 2024 | Apr 3, 2024 | Mohan Raju | CEO | Sell | 51.3 | -4,312 | -0.27% | ✗ | $23.3K |
| Apr 2, 2024 | Apr 3, 2024 | Auster Martin | CFO | Sell | 47.5 | -1,405 | -5.47% | ✗ | $7.6K |
| Mar 28, 2024 | Mar 29, 2024 | Krueger Christopher W | CHIEF BUSINESS OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 28, 2024 | Mar 29, 2024 | Auster Martin | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 28, 2024 | Mar 29, 2024 | Mohan Raju | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 28, 2024 | Mar 29, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2024 | Jan 23, 2024 | White William Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2024 | Jan 23, 2024 | Subramaniam Somu | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2024 | Jan 23, 2024 | HULME ALLISON | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2024 | Jan 23, 2024 | Cadoret-Manier Onaiza | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 21, 2024 | Jan 23, 2024 | Gujrathi Sheila | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2024 | Jan 3, 2024 | Auster Martin | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2024 | Jan 3, 2024 | Mohan Raju | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2024 | Jan 3, 2024 | Nuss John | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 2, 2024 | Jan 3, 2024 | Krueger Christopher W | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 20, 2023 | Dec 21, 2023 | Nuss John | Chief Scientific Officer | Sell | 46.3 | -17,628 | -6.30% | ✗ | $37.3K |
| Dec 20, 2023 | Dec 21, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 46.3 | -5,293 | -1.84% | ✗ | $11.2K |
| Dec 20, 2023 | Dec 21, 2023 | Mohan Raju | CEO | Sell | 42.5 | -58,860 | -3.61% | ✗ | $124.7K |
| Dec 17, 2023 | Dec 19, 2023 | Mohan Raju | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 17, 2023 | Dec 19, 2023 | Nuss John | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 17, 2023 | Dec 19, 2023 | Krueger Christopher W | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 18, 2023 | Dec 19, 2023 | Auster Martin | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 9, 2023 | Oct 11, 2023 | NSV Partners III LP | 10% Owner | Sell | 42.5 | -49,152 | -0.58% | ✓ | $1.5M |
| Oct 9, 2023 | Oct 11, 2023 | Subramaniam Somu | Director | Sell | 42.5 | -49,152 | -0.58% | ✓ | $1.5M |
| Oct 5, 2023 | Oct 6, 2023 | Mohan Raju | CEO | Sell | 42.5 | -30,000 | -1.94% | ✓ | $873.2K |
| Oct 3, 2023 | Oct 4, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 30.0 | -15,000 | -5.14% | ✓ | $449.7K |
| Oct 3, 2023 | Oct 4, 2023 | Nuss John | Chief Scientific Officer | Sell | 35.0 | -10,000 | -3.92% | ✓ | $299.9K |
| Sep 18, 2023 | Sep 20, 2023 | Subramaniam Somu | Director | Sell | 42.5 | -56,665 | -0.66% | ✓ | $2.1M |
| Sep 18, 2023 | Sep 20, 2023 | NSV Partners III LP | 10% Owner | Sell | 42.5 | -56,665 | -0.66% | ✓ | $2.1M |
| Sep 5, 2023 | Sep 7, 2023 | Auster Martin | CFO | Sell | 7.5 | -26,472 | -55.56% | ✓ | $863.3K |
| Sep 5, 2023 | Sep 7, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 30.0 | -15,000 | -5.14% | ✓ | $489.1K |
| Sep 5, 2023 | Sep 7, 2023 | Mohan Raju | CEO | Sell | 42.5 | -30,000 | -1.94% | ✓ | $978.3K |
| Sep 5, 2023 | Sep 7, 2023 | Nuss John | Chief Scientific Officer | Sell | 35.0 | -10,000 | -3.92% | ✓ | $326K |
| Aug 31, 2023 | Sep 1, 2023 | Sandborn William J. | Officer | Sell | 22.5 | -11,900 | -14.09% | ✓ | $400.4K |
| Aug 8, 2023 | Aug 8, 2023 | Sandborn William J. | Officer | Sell | 37.5 | -3,494 | -4.59% | ✓ | $114.8K |
| Aug 7, 2023 | Aug 8, 2023 | Mohan Raju | CEO | Sell | 40.0 | -30,000 | -1.94% | ✓ | $1M |
| Aug 3, 2023 | Aug 4, 2023 | Nuss John | Chief Scientific Officer | Sell | 35.0 | -10,000 | -3.92% | ✓ | $356K |
| Aug 3, 2023 | Aug 4, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 30.0 | -15,000 | -5.14% | ✓ | $533.8K |
| Jul 3, 2023 | Aug 4, 2023 | Krueger Christopher W | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 28, 2023 | Aug 1, 2023 | Subramaniam Somu | Director | Sell | 47.5 | -11,414 | -0.13% | ✓ | $429K |
| Jul 28, 2023 | Aug 1, 2023 | NSV Partners III LP | 10% Owner | Sell | 47.5 | -11,414 | -0.13% | ✓ | $429K |
| Jul 31, 2023 | Aug 1, 2023 | Sandborn William J. | Officer | Sell | 22.5 | -11,900 | -13.53% | ✓ | $442.3K |
| Jul 25, 2023 | Jul 26, 2023 | Auster Martin | CFO | Sell | 7.5 | -28,000 | -37.01% | ✓ | $995K |
| Jul 7, 2023 | Jul 19, 2023 | NSV Partners III LP | 10% Owner | Sell | 27.5 | -1,064,178 | -5.53% | ✓ | $3.5M |
| Jul 7, 2023 | Jul 19, 2023 | Subramaniam Somu | Director | Sell | 20.0 | -1,064,178 | -11.02% | ✓ | $3.5M |